We also assessed the mRNA expression levels of IGF1R and found that 12 out of 144 (8%) NSCLC samples have >2 fold IGF1R mRNA expression than the normal lung samples in the panel 1. The gene discussed is IGF1R; the disease is non-small cell lung carcinoma.